3/12
10:22 am
atxs
Rating for ATXS
Medium
Report
Rating for ATXS
3/12
10:22 am
atxs
Rating for ATXS
Medium
Report
Rating for ATXS
3/12
09:12 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush.
3/12
09:12 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush.
3/11
01:27 pm
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
2/27
12:38 pm
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
1/31
11:55 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
1/31
11:55 am
atxs
Rating for ATXS
Low
Report
Rating for ATXS
1/31
07:33 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $26.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $26.00 price target on the stock.
1/31
07:33 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $26.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $26.00 price target on the stock.
1/31
04:58 am
atxs
Astria Therapeutics initiated with an Outperform at JMP Securities
Medium
Report
Astria Therapeutics initiated with an Outperform at JMP Securities
1/31
04:58 am
atxs
Astria Therapeutics initiated with an Outperform at JMP Securities
Medium
Report
Astria Therapeutics initiated with an Outperform at JMP Securities
1/23
12:50 pm
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
1/13
10:58 am
atxs
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Low
Report
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.